{"disease":{"id":"secondarily-infected-traumatic-lesions","name":"secondarily infected traumatic lesions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04155203","title":"To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":657,"lead_sponsor_name":"Padagis LLC","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}